Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) last traded at ₹32.1, a market capitalisation of ₹52.2 crore, on a P/E of 109. Over the past 52 weeks the stock has ranged between ₹25.6 and ₹46.8. Biofil Chemicals & Pharmaceuticals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹12.35 crore and net profit of ₹0.11 crore. Biofil Chemicals & Pharmaceuticals Ltd’s annual general meeting is scheduled for 23 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Biofil Chemicals & Pharmaceuticals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Biofil Chemicals & Pharmaceuticals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹12.35 cr, up 92.1% from ₹6.43 cr a year earlier. Net profit was ₹0.11 cr, down 95.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2.41 | 14.2 | 8.35 | 6.43 | 13.54 | 0.86 | 7.57 | 12.35 |
| Expenses | 2.29 | 13.89 | 8.24 | 6.42 | 13.42 | 0.77 | 7.14 | 12.21 |
| Operating profit | 0.12 | 0.31 | 0.11 | 0.01 | 0.12 | 0.09 | 0.43 | 0.14 |
| OPM % | 4.98% | 2.18% | 1.32% | 0.16% | 0.89% | 10.47% | 5.68% | 1.13% |
| Other income | 0.02 | 0.02 | 0.24 | 2.83 | 0.06 | 0.08 | 0.11 | 0.06 |
| Interest | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
| Depreciation | 0.1 | 0.1 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Profit before tax | 0.03 | 0.22 | 0.26 | 2.76 | 0.11 | 0.1 | 0.47 | 0.13 |
| Tax % | 33.33% | 27.27% | 23.08% | 12.68% | 27.27% | 30.00% | 55.32% | 23.08% |
| Net profit | 0.02 | 0.16 | 0.2 | 2.41 | 0.08 | 0.08 | 0.21 | 0.11 |
| EPS (₹) | 0.01 | 0.10 | 0.12 | 1.48 | 0.05 | 0.05 | 0.13 | 0.07 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Biofil Chemicals & Pharmaceuticals Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 35.75 | 22.38 | 30.04 | 40.04 | 33.4 | 28.4 | 34.32 |
| Operating profit | 1.6 | 1.33 | 1.16 | 0.81 | 0.85 | 0.65 | 0.78 |
| OPM % | 4.48% | 5.94% | 3.86% | 2.02% | 2.54% | 2.29% | 2.27% |
| Net profit | 1.24 | 0.7 | 0.56 | 0.71 | 0.56 | 2.79 | 0.48 |
| EPS (₹) | 0.76 | 0.43 | 0.34 | 0.44 | 0.34 | 1.71 | 0.30 |
TTM is the trailing twelve months to the most recent quarter.
Biofil Chemicals & Pharmaceuticals Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- -5%
- 3 Years
- -2%
- TTM
- 9%
- 10 Years
- 14%
- 5 Years
- 18%
- 3 Years
- 71%
- TTM
- -83%
- 10 Years
- 17%
- 5 Years
- -13%
- 3 Years
- -12%
- 1 Year
- -25%
- 10 Years
- 7%
- 5 Years
- 6%
- 3 Years
- 7%
- Last Year
- 14%
Biofil Chemicals & Pharmaceuticals Ltd shareholding pattern
Promoters held 46.79% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 0.08%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 46.82% | 46.82% | 46.82% | 46.82% | 46.79% | 46.79% | 46.79% | 46.79% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% | 0.08% |
| Public | 53.10% | 53.11% | 53.11% | 53.10% | 53.12% | 53.13% | 53.12% | 53.13% |
| No. of shareholders | 26,422 | 26,114 | 25,914 | 25,685 | 25,196 | 24,825 | 25,356 | 24,999 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Biofil Chemicals & Pharmaceuticals Ltd’s AGM?
Biofil Chemicals & Pharmaceuticals Ltd’s annual general meeting is scheduled for 23 Sept 2026.
- AGMConvening of 41st Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Biofil Chemicals & Pharmaceuticals Ltd corporate filings
- Newspaper publication of Notice of 41st AGM through Video Conferencing (''''VC'''')/ Other Audio Visual Means (''''OAVM'''')Company Updatelow impact
Cruxal's analysis: Biofil Chemicals and Pharmaceuticals Limited has issued a formal notice for its 41st…
Read the full analysis - Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015Company Updatelow impact
Cruxal's analysis: Biofil Chemicals and Pharmaceuticals Limited has published its unaudited financial…
Read the full analysis - Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company, notwithstanding his attaining the age of 75 (Seventy Five )YearsCompany Updatelow impact
Cruxal's analysis: Biofil Chemicals and Pharmaceuticals Limited has disclosed the board's approval for the…
Read the full analysis - Outcome of Board Meeting held on Tuesday 11th August, 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Board Meetinghigh impact
Cruxal's analysis: Biofil Chemicals and Pharmaceuticals Limited reported a significant increase in revenue…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Biofil Chemicals & Pharmaceuticals Ltd
Cruxal reads every Biofil Chemicals & Pharmaceuticals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.